Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions

Significance Cancer progression, as an evolutionary process, should accelerate if higher cellular variability is present. However, the sources of nongenetic variability in metastatic progression are largely unknown. To address this question, we characterized a transcriptional regulatory network for the metastasis suppressor Raf kinase inhibitory protein (RKIP). We previously showed that the transcription factor BACH1 is negatively regulated by RKIP and promotes breast cancer metastasis. Here we reveal a network architecture between the metastasis suppressor RKIP and the metastasis promoter BACH1 that enables single cells to generate a stable subpopulation of prometastatic cells without any genetic changes. The sources and consequences of nongenetic variability in metastatic progression are largely unknown. To address these questions, we characterized a transcriptional regulatory network for the metastasis suppressor Raf kinase inhibitory protein (RKIP). We previously showed that the transcription factor BACH1 is negatively regulated by RKIP and promotes breast cancer metastasis. Here we demonstrate that BACH1 acts in a double-negative (overall positive) feedback loop to inhibit RKIP transcription in breast cancer cells. BACH1 also negatively regulates its own transcription. Analysis of the BACH1 network reveals the existence of an inverse relationship between BACH1 and RKIP involving both monostable and bistable transitions that can potentially give rise to nongenetic variability. Single-cell analysis confirmed monostable and bistable-like behavior. Treatment with histone deacetylase inhibitors or depletion of the polycomb repressor enhancer of zeste homolog 2 altered relative RKIP and BACH1 levels in a manner consistent with a prometastatic state. Together, our results suggest that the mutually repressive relationship between metastatic regulators such as RKIP and BACH1 can play a key role in determining metastatic progression in cancer.

[1]  J. Collins,et al.  Construction of a genetic toggle switch in Escherichia coli , 2000, Nature.

[2]  Gábor Balázsi,et al.  Mapping the Environmental Fitness Landscape of a Synthetic Gene Circuit , 2012, PLoS Comput. Biol..

[3]  T. Giordano,et al.  Raf kinase inhibitory protein inhibits beta-cell proliferation. , 2004, Surgery.

[4]  J. Ellenberg,et al.  The quantitative proteome of a human cell line , 2011, Molecular systems biology.

[5]  K. Becker,et al.  Analysis of microarray data using Z score transformation. , 2003, The Journal of molecular diagnostics : JMD.

[6]  Eshel Ben-Jacob,et al.  MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination , 2013, Proceedings of the National Academy of Sciences.

[7]  Edward R Sumner,et al.  Glutathione and Gts1p drive beneficial variability in the cadmium resistances of individual yeast cells , 2007, Molecular microbiology.

[8]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[9]  S. Dangi‐Garimella,et al.  Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let‐7 , 2009, The EMBO journal.

[10]  Eduardo Sontag,et al.  Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Rosner,et al.  Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. , 2008, Expert opinion on therapeutic targets.

[12]  Hemant Ishwaran,et al.  Signalling pathway for RKIP and Let‐7 regulates and predicts metastatic breast cancer , 2011, The EMBO journal.

[13]  Peter Dirks,et al.  Cancer stem cells: an evolving concept , 2012, Nature Reviews Cancer.

[14]  J. Ferrell.  Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. , 2002, Current opinion in cell biology.

[15]  K. Polyak,et al.  Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.

[16]  T. Borodina,et al.  The BTB and CNC Homology 1 (BACH1) Target Genes Are Involved in the Oxidative Stress Response and in Control of the Cell Cycle* , 2011, The Journal of Biological Chemistry.

[17]  R. Mehra,et al.  Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. , 2012, Cancer research.

[18]  B. Snijder,et al.  Origins of regulated cell-to-cell variability , 2011, Nature Reviews Molecular Cell Biology.

[19]  W. Kolch,et al.  Snail is a repressor of RKIP transcription in metastatic prostate cancer cells , 2008, Oncogene.

[20]  Daniel A Charlebois,et al.  Gene expression noise facilitates adaptation and drug resistance independently of mutation. , 2011, Physical review letters.

[21]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[22]  James E. Ferrell,et al.  Bistability in cell signaling: How to make continuous processes discontinuous, and reversible processes irreversible. , 2001, Chaos.

[23]  R. Milo,et al.  Dynamic Proteomics of Individual Cancer Cells in Response to a Drug , 2008, Science.

[24]  C. Burge,et al.  The microRNAs of Caenorhabditis elegans. , 2003, Genes & development.

[25]  B. Bonavida,et al.  Mechanisms of nitric oxide-mediated inhibition of EMT in cancer , 2010, Cell cycle.

[26]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[27]  T. Noda,et al.  Bach1 inhibits oxidative stress–induced cellular senescence by impeding p53 function on chromatin , 2008, Nature Structural &Molecular Biology.

[28]  A. Zambrano,et al.  Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[29]  X. Chen,et al.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.

[30]  R. Gentleman,et al.  Independent filtering increases detection power for high-throughput experiments , 2010, Proceedings of the National Academy of Sciences.

[31]  Ben S. Wittner,et al.  A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.

[32]  M. Rubin,et al.  Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. , 2003, Journal of the National Cancer Institute.

[33]  Xin Liu,et al.  Dynamical and Structural Analysis of a T Cell Survival Network Identifies Novel Candidate Therapeutic Targets for Large Granular Lymphocyte Leukemia , 2011, PLoS Comput. Biol..

[34]  Hannah H. Chang,et al.  Non-genetic heterogeneity — a mutation-independent driving force for the somatic evolution of tumours , 2009, Nature Reviews Genetics.

[35]  T. Giordano,et al.  Raf kinase inhibitory protein inhibits β-cell proliferation , 2004 .

[36]  A. Oudenaarden,et al.  Cellular Decision Making and Biological Noise: From Microbes to Mammals , 2011, Cell.

[37]  Rita Strack,et al.  A noncytotoxic DsRed variant for whole-cell labeling , 2008, Nature Methods.

[38]  Steven A. Frank,et al.  Nonheritable Cellular Variability Accelerates the Evolutionary Processes of Cancer , 2012, PLoS biology.

[39]  Farren J. Isaacs,et al.  Phenotypic consequences of promoter-mediated transcriptional noise. , 2006, Molecular cell.

[40]  A. G. de Herreros,et al.  Snail1 transcriptional repressor binds to its own promoter and controls its expression , 2006, Nucleic acids research.

[41]  Z. Werb,et al.  Roadblocks to translational advances on metastasis research , 2013, Nature Medicine.

[42]  P. Sorger,et al.  Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.

[43]  O. Kuipers,et al.  Bistability, epigenetics, and bet-hedging in bacteria. , 2008, Annual review of microbiology.

[44]  Guy S. Salvesen,et al.  SnapShot: Caspases , 2011, Cell.